Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
2008 StandoutScience
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
Metastasis: from dissemination to organ-specific colonization
2009 Standout
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
2001
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
2003
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
2002
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
2003
Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
2003
Hallmarks of Cancer: The Next Generation
2011 Standout
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen‐receptor status and predicts for poor prognosis
2003
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
2005
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Clinical Significance of Bone Marrow Micrometastasis Detected by Nested RT-PCR for Keratin-19 in Breast Cancer Patients
2003
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
2010
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
High-resolution array comparative genomic hybridization of single micrometastatic tumor cells
2008
Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry
2001
Cancer to bone: a fatal attraction
2011 Standout
Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer
2003
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer
2010
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003
Imaging in the era of molecular oncology
2008 StandoutNature
A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood
2001
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
2014
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Significance, detection and markers of disseminated breast cancer cells
2006
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell—The Unit of Selection
2003
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer
2008
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients
2003
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
A molecular signature of metastasis in primary solid tumors
2002 Standout
Bone Marrow Micrometastases and Adjuvant Treatment of Breast Cancer
2004
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Ductal Carcinoma In Situ, Complexities and Challenges
2004
A role for Wnt signalling in self-renewal of haematopoietic stem cells
2003 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
2002
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage
2004
Angiogenesis and Blood Vessel Invasion as Prognostic Indicators for Node-Negative Breast Cancer
2001
Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes
2003
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
2001 Nature
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Clonal evolution in cancer
2012 StandoutNature
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
2005
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Systemic Spread Is an Early Step in Breast Cancer
2008
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Identification of human brain tumour initiating cells
2004 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Missed micrometastatic disease in breast cancer
2004
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Wnt signalling in stem cells and cancer
2005 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Breast cancer metastasis: markers and models
2005 Standout
Detection of carcinoma cells in the blood of breast cancer patients
2000
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System
2004
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients
2004
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
2003
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
2003
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
2002
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
2004
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells
2004
Metabolic reprogramming and cancer progression
2020 StandoutScience
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
2006
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
2001
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood
2001
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
2003
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
2001
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of T. Dimpfl being referenced
Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium
1999
Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?
2003
Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma
2000
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Prognostic relevance of immunohistology, tumor size and vascular space involvement in axillary node negative breast cancer
1998
Intraductal carcinoma (DCIS) of the breast. Risk-adapted tumor surgery with axillary lymphadenectomy?
1996